Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Transenterix Inc (TRXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,831
  • Shares Outstanding, K 217,041
  • Annual Sales, $ 24,100 K
  • Annual Income, $ -61,780 K
  • 60-Month Beta 2.50
  • Price/Sales 21.25
  • Price/Cash Flow N/A
  • Price/Book 3.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.07
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.09
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.20 +0.91%
on 03/20/19
3.33 -33.33%
on 02/25/19
-1.03 (-31.69%)
since 02/22/19
3-Month
2.05 +8.29%
on 12/24/18
3.33 -33.33%
on 02/25/19
+0.02 (+0.91%)
since 12/21/18
52-Week
1.60 +38.75%
on 03/28/18
6.98 -68.19%
on 09/25/18
+0.54 (+32.14%)
since 03/22/18

Most Recent Stories

More News
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TransEnterix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of...

TRXC : 2.22 (-5.93%)
Transenterix Inc Set to Possibly Rebound After Yesterday's Selloff of 6.95%

Transenterix Inc (AMEX:TRXC) traded in a range yesterday that spanned from a low of $2.63 to a high of $3.23. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $2.91...

TRXC : 2.22 (-5.93%)
TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2018

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced...

TRXC : 2.22 (-5.93%)
Key Factors to Know Ahead of TransEnterix (TRXC) Q4 Earnings

TransEnterix (TRXC) is anticipated to witness robust top-line growth in Q4 on the back of multiple product developments.

MGNX : 18.98 (-4.24%)
TGTX : 6.83 (-7.58%)
BDSI : 5.11 (-3.58%)
TRXC : 2.22 (-5.93%)
TransEnterix Schedules Fourth Quarter and Fiscal Year 2018 Financial and Operating Results Conference Call for February 26, 2019

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February...

TRXC : 2.22 (-5.93%)
SmarTrend Watching for Potential Pullback in Shares of Transenterix Inc After 2.76% Gain

Transenterix Inc (AMEX:TRXC) traded in a range yesterday that spanned from a low of $2.44 to a high of $2.65. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $2.61...

TRXC : 2.22 (-5.93%)
TransEnterix Receives FDA 510(k) Clearance for Senhance Ultrasonic System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the...

TRXC : 2.22 (-5.93%)
TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference

SOURCE: TransEnterix, Inc.

TRXC : 2.22 (-5.93%)
Emerging Medical Device Market Expected to Exceed $400 Billion by 2023

Financialnewsmedia.com News Commentary

ETST : 0.7000 (-2.64%)
PBYI : 39.03 (-3.37%)
JNJ : 136.91 (-0.86%)
CERS : 6.16 (-4.64%)
TRXC : 2.22 (-5.93%)
Are Options Traders Betting on a Big Move in TransEnterix (TRXC) Stock?

Investors need to pay close attention to TransEnterix (TRXC) stock based on the movements in the options market lately.

TRXC : 2.22 (-5.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TRXC with:

Business Summary

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the...

See More

Key Turning Points

2nd Resistance Point 2.39
1st Resistance Point 2.31
Last Price 2.22
1st Support Level 2.18
2nd Support Level 2.13

See More

52-Week High 6.98
Fibonacci 61.8% 4.92
Fibonacci 50% 4.29
Fibonacci 38.2% 3.66
Last Price 2.22
52-Week Low 1.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar